Available now: Open-access interviews with experts on the COVID-19 pandemic: epidemiology, virus biology and possible vaccines and treatmentsView All
Dr. Sally John Division of Epidemiology and Health Sciences, University of Manchester, UK1 Talk
Sally John, PhD, is a Senior Lecturer at the University of Manchester and has pursued research into the genetic basis of complex traits within both academia and the pharmaceutical industry. Her main interest has been the genetic basis of inflammatory disease and she has published extensively in this area. Her... read moreinterest in addressing analysis and study design aspects of large population based genetic studies has led to her involvement in other disease areas and pharmacogenetic research. Nick Davies joined Pfizer in July 2005 and is a Senior Director and Europe and Japan Site Head for the Strategic Management Group. He is responsible for developing and leading key strategic initiatives to drive the organization to meet future patient needs for innovative new medicines and shareholder expectations for continued growth. Nick received his BSc in biology in 1990 and a PhD in molecular biology and immunology from Cambridge University in 1993 before completing his postdoctoral studies with Professor Bob Williamson in the Department of Biochemistry at St. Mary's Medical School, Imperial College London.